This trial is !
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
HIV
and you are
between 18 and 99
years old
Phase
3
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

The project presented here will be the first prospective, randomized evaluation of the effect of ART on the structure and function of the gut microbiome. This study provides a unique opportunity to understand the benefits of ART with high intestinal penetration on the gut microbiome. It is thus a key study to understand the bidirectional interactions between the microbiome and the host in people living with HIV/AIDS.

Provided treatments

  • Drug: Raltegravir
  • Drug: Placebo
  • Drug: Current ART
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03029689. The sponsor of the trial is Fundacio Lluita Contra la SIDA and it is looking for 60 volunteers for the current phase.
Official trial title:
Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Effect of Raltegravir Intensification (1.200 mg QD) on the Gut Microbiota of Chronically HIV-1 Infected Subject Over Time: THE RAGTIME